Behavioral
Riverbend Medical Group, INC.
Riverbend Medical Group, INC. was paid $38.70M by Medicaid between Jan 2018 and Dec 2024, across 276 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
33Billing provider infoRIVERBEND MEDICAL GROUP, INC.
SPRINGFIELD, MA 01104
SPRINGFIELD, MA 01104
33aNPI1841651197assigned 03/15/2016
33bProvider typePsychologist
28Total paid$38.70M
24GClaims1,182,216
24DCodes billed276
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Psychologist providers in Massachusetts
Rank by total paid#1 of 91
Median peer was paid$38K
This provider vs. median1,013×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HARRIS, JAMES controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 263,339 | $7.95M | |
| 2019 | 191,506 | $7.89M | |
| 2020 | 143,395 | $6.27M | |
| 2021 | 143,732 | $5.89M | |
| 2022 | 144,071 | $5.44M | |
| 2023 | 168,454 | $3.47M | |
| 2024incomplete | 127,719 | $1.80M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 281,441 | 272,594 | $14.04M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 190,129 | 184,567 | $7.36M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.7% | 46,307 | 45,879 | $1.45M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.0% | 19,231 | 19,195 | $1.17M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.9% | 19,421 | 18,448 | $1.13M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.8% | 18,290 | 18,255 | $1.07M |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.6% | 12,921 | 12,504 | $1.01M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.4% | 10,914 | 10,818 | $941K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.0% | 76,579 | 75,574 | $790K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.0% | 14,616 | 14,523 | $774K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 1.8% | 78,428 | 77,589 | $683K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.7% | 10,464 | 10,442 | $641K |
264 more codes
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.0% | 5,992 | $392K |
| 92551 | <1% | 38,494 | $364K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 3,334 | $358K |
| 76830 | Ultrasound, transvaginal | <1% | 3,745 | $301K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 4,117 | $292K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 4,174 | $286K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 12,424 | $218K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 4,624 | $183K |
| 98940 | <1% | 9,013 | $179K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 6,590 | $178K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 11,032 | $172K |
| 72110 | <1% | 5,416 | $153K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 2,092 | $137K |
| 94060 | <1% | 6,865 | $132K | |
| 90674 | <1% | 7,179 | $128K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 2,717 | $124K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 9,494 | $117K |
| 20610 | <1% | 3,780 | $117K | |
| 94729 | <1% | 6,472 | $116K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,620 | $111K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 4,387 | $106K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,372 | $106K |
| 73630 | <1% | 5,841 | $99K | |
| 97802 | <1% | 1,056 | $97K | |
| 99051 | <1% | 5,789 | $96K | |
| 76536 | <1% | 1,346 | $95K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 713 | $92K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 712 | $92K |
| 94727 | <1% | 6,034 | $85K | |
| 99443 | <1% | 4,878 | $84K | |
| 17110 | <1% | 1,235 | $84K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,376 | $80K |
| 11721 | <1% | 4,826 | $74K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,905 | $73K |
| 95886 | <1% | 804 | $72K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,867 | $72K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,022 | $71K |
| 80061 | Lipid panel | <1% | 9,026 | $64K |
| 43775 | <1% | 97 | $62K | |
| 64483 | <1% | 693 | $61K | |
| 73562 | <1% | 2,583 | $60K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 414 | $57K |
| 76642 | <1% | 1,034 | $57K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 860 | $52K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,590 | $51K |
| 73030 | <1% | 2,898 | $51K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 6,717 | $51K |
| 73564 | <1% | 1,771 | $49K | |
| 62323 | <1% | 496 | $48K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 415 | $48K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 373 | $43K |
| 76801 | <1% | 528 | $42K | |
| 72050 | <1% | 1,431 | $40K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 405 | $38K |
| 76813 | <1% | 481 | $38K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,346 | $35K |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | <1% | 295 | $35K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 532 | $35K |
| 80053 | Comprehensive metabolic panel | <1% | 6,079 | $35K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 342 | $32K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,132 | $32K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,239 | $32K |
| 95911 | <1% | 216 | $30K | |
| 81025 | <1% | 4,727 | $30K | |
| 11102 | <1% | 409 | $30K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 568 | $30K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 702 | $29K |
| 99442 | <1% | 1,582 | $25K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,262 | $24K |
| 11056 | <1% | 1,079 | $24K | |
| 71250 | <1% | 327 | $23K | |
| 95811 | <1% | 65 | $21K | |
| 73130 | <1% | 1,036 | $21K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 273 | $21K |
| 99205 | Prolong outpt/office vis | <1% | 138 | $20K |
| 97803 | <1% | 564 | $20K | |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 711 | $20K |
| 80305 | <1% | 2,314 | $19K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 740 | $19K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 478 | $19K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 70 | $18K |
| 11100 | <1% | 243 | $18K | |
| 93975 | <1% | 87 | $17K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 4,644 | $16K |
| 93015 | <1% | 274 | $15K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 311 | $15K |
| 95251 | <1% | 1,191 | $14K | |
| 20550 | <1% | 416 | $14K | |
| 80050 | General health panel | <1% | 819 | $13K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 215 | $13K |
| 77065 | Tomosynthesis, mammo | <1% | 212 | $13K |
| 95117 | <1% | 1,621 | $12K | |
| 99460 | <1% | 117 | $12K | |
| 85027 | <1% | 2,016 | $11K | |
| 90756 | <1% | 631 | $11K | |
| 93000 | <1% | 1,023 | $10K | |
| 96900 | <1% | 691 | $10K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 70 | $10K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 134 | $9K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 91 | $9K |
| 87210 | <1% | 1,871 | $8K | |
| G0127 | Trimming of dystrophic nails, any number | <1% | 907 | $8K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 1,365 | $8K |
| 94726 | <1% | 419 | $8K | |
| 86780 | <1% | 596 | $7K | |
| 87808 | <1% | 686 | $7K | |
| 87081 | <1% | 1,055 | $7K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 183 | $7K |
| 11750 | <1% | 85 | $6K | |
| 36478 | <1% | 13 | $6K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 47 | $6K |
| 94618 | <1% | 497 | $6K | |
| 95909 | <1% | 69 | $6K | |
| 0011A | <1% | 154 | $6K | |
| 82962 | <1% | 3,616 | $6K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 111 | $6K |
| 73110 | <1% | 279 | $6K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 241 | $6K |
| 94010 | <1% | 282 | $6K | |
| 73502 | <1% | 256 | $6K | |
| 90670 | <1% | 1,288 | $5K | |
| 99223 | Prolong inpt eval add15 m | <1% | 91 | $5K |
| 0012A | <1% | 129 | $5K | |
| 90715 | <1% | 219 | $5K | |
| 85610 | <1% | 3,167 | $5K | |
| 73610 | <1% | 229 | $5K | |
| 37765 | <1% | 27 | $5K | |
| 90662 | <1% | 323 | $4K | |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 473 | $4K |
| 99403 | <1% | 75 | $4K | |
| 59025 | Fetal non-stress test | <1% | 169 | $4K |
| 29848 | <1% | 14 | $4K | |
| 77066 | Tomosynthesis, mammo | <1% | 50 | $4K |
| 62321 | <1% | 55 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 253 | $4K |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 213 | $4K |
| 82043 | <1% | 1,189 | $4K | |
| 82570 | <1% | 1,174 | $3K | |
| 98968 | <1% | 182 | $3K | |
| 51701 | <1% | 118 | $3K | |
| 90661 | <1% | 130 | $3K | |
| 97597 | <1% | 287 | $3K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 78 | $2K |
| 87634 | <1% | 48 | $2K | |
| 99386 | <1% | 25 | $2K | |
| 96127 | <1% | 581 | $2K | |
| 86803 | <1% | 200 | $2K | |
| ATP14 | <1% | 1,252 | $2K | |
| 73140 | <1% | 109 | $2K | |
| 77080 | <1% | 196 | $2K | |
| ATP17 | <1% | 1,332 | $2K | |
| 43235 | <1% | 26 | $2K | |
| 80074 | <1% | 44 | $2K | |
| 86140 | <1% | 576 | $2K | |
| 72070 | <1% | 73 | $2K | |
| 84460 | <1% | 638 | $2K | |
| 84450 | <1% | 639 | $2K | |
| 95024 | <1% | 31 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,719 | $2K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 28 | $1K |
| 99397 | <1% | 14 | $1K | |
| 90651 | <1% | 610 | $1K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 818 | $1K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 76 | $1K |
| 90694 | <1% | 200 | $1K | |
| 73221 | <1% | 39 | $1K | |
| 84439 | <1% | 178 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 49 | $1K |
| 81001 | <1% | 582 | $1K | |
| ATP08 | <1% | 1,288 | $1K | |
| 29540 | <1% | 95 | $1K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 24 | $1K |
| 98967 | <1% | 74 | $1K | |
| 85651 | <1% | 543 | $1K | |
| ATP11 | <1% | 873 | $1K | |
| 82607 | <1% | 119 | $1K | |
| 99188 | <1% | 44 | $991.90 | |
| 72141 | <1% | 25 | $979.58 | |
| 73565 | <1% | 51 | $974.56 | |
| 90480 | <1% | 27 | $966.64 | |
| ATP03 | <1% | 448 | $947.28 | |
| 11730 | <1% | 13 | $864.90 | |
| 93971 | <1% | 14 | $852.59 | |
| 20611 | <1% | 12 | $745.91 | |
| 20526 | <1% | 13 | $690.70 | |
| G0008 | Administration of influenza virus vaccine | <1% | 552 | $591.59 |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 27 | $590.11 |
| 83550 | <1% | 97 | $570.24 | |
| 76770 | <1% | 12 | $486.12 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 133 | $459.91 |
| 99173 | <1% | 248 | $424.87 | |
| 82465 | <1% | 84 | $377.83 | |
| 84153 | <1% | 24 | $342.51 | |
| 82565 | <1% | 180 | $323.38 | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 13 | $300.55 |
| 99177 | <1% | 90 | $288.30 | |
| 83970 | <1% | 17 | $285.67 | |
| 90688 | <1% | 1,415 | $272.90 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 27 | $262.82 |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 15 | $257.16 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 224 | $256.25 |
| 71045 | Radiologic examination, chest; single view | <1% | 68 | $234.32 |
| 99493 | <1% | 160 | $213.74 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 17 | $202.13 |
| ATP15 | <1% | 71 | $196.02 | |
| 74220 | <1% | 12 | $172.46 | |
| ATP07 | <1% | 75 | $160.17 | |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | <1% | 12 | $145.28 |
| 95012 | <1% | 64 | $143.18 | |
| 86705 | <1% | 13 | $139.37 | |
| 94762 | <1% | 13 | $133.70 | |
| 81002 | <1% | 56 | $130.31 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 244 | $126.44 |
| 80051 | <1% | 33 | $125.68 | |
| 87340 | <1% | 13 | $122.28 | |
| 86431 | <1% | 30 | $118.05 | |
| 86706 | <1% | 12 | $113.12 | |
| 86580 | <1% | 14 | $92.72 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 13 | $82.29 |
| 90686 | <1% | 867 | $71.09 | |
| 84520 | <1% | 45 | $70.69 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 50 | $63.93 |
| 80076 | <1% | 15 | $62.99 | |
| 84100 | <1% | 42 | $40.16 | |
| ATP13 | <1% | 191 | $32.67 | |
| 82310 | <1% | 25 | $21.03 | |
| 90685 | <1% | 582 | $19.52 | |
| 99000 | <1% | 15 | $13.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 25 | $12.57 |
| ATP05 | <1% | 12 | $8.06 | |
| 3074F | 0% | 1,265 | $0.00 | |
| 90698 | 0% | 627 | $0.00 | |
| 90680 | 0% | 1,269 | $0.00 | |
| 3048F | 0% | 1,515 | $0.00 | |
| G8428 | Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given | 0% | 671 | $0.00 |
| 90656 | 0% | 177 | $0.00 | |
| 3061F | 0% | 441 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 916 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 82 | $0.00 |
| 90716 | 0% | 611 | $0.00 | |
| 90744 | 0% | 362 | $0.00 | |
| 90723 | 0% | 41 | $0.00 | |
| 90474 | 0% | 25 | $0.00 | |
| 99494 | 0% | 12 | $0.00 | |
| 3060F | 0% | 42 | $0.00 | |
| 90696 | 0% | 26 | $0.00 | |
| G8599 | Aspirin or another antiplatelet therapy not used, reason not given | 0% | 12 | $0.00 |
| 4040F | 0% | 4,272 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 24,462 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 12,946 | $0.00 |
| 90633 | 0% | 739 | $0.00 | |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 14,110 | $0.00 |
| 90461 | 0% | 3,016 | $0.00 | |
| 4004F | 0% | 1,073 | $0.00 | |
| 3078F | 0% | 1,873 | $0.00 | |
| G8400 | Patient with central dual-energy x-ray absorptiometry (dxa) results not documented, reason not given | 0% | 103 | $0.00 |
| 90734 | 0% | 436 | $0.00 | |
| 90648 | 0% | 127 | $0.00 | |
| 90707 | 0% | 545 | $0.00 | |
| 90687 | 0% | 55 | $0.00 | |
| 90714 | 0% | 30 | $0.00 | |
| 90700 | 0% | 25 | $0.00 | |
| 3045F | 0% | 13 | $0.00 | |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHARRIS, JAMES (REGIONAL DIRECTOR OF REIMBURSEMENT)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.